Acta Med. 1999, 42: 85-88
https://doi.org/10.14712/18059694.2019.148
Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia
Crossref Cited-by Linking
- Arons Evgeny, Margulies Inger, Sorbara Lynn, Raffeld Mark, Stetler-Stevenson Maryalice, Pastan Ira, Kreitman Robert J.: Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction. Clinical Cancer Research 2006, 12, 2804. <https://doi.org/10.1158/1078-0432.CCR-05-2315>
- Kreitman Robert J., Squires David R., Stetler-Stevenson Maryalice, Noel Pierre, FitzGerald David J.P., Wilson Wyndham H., Pastan Ira: Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies. JCO 2005, 23, 6719. <https://doi.org/10.1200/JCO.2005.11.437>